Phar­ma in­vestors brush off Trump’s ‘most fa­vored na­tion’ plan as stocks rise

Pres­i­dent Don­ald Trump on Mon­day made a sweep­ing promise to bring down drug prices and stop phar­ma com­pa­nies from tak­ing ad­van­tage of the US. Wall …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA